Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Properties of a concentrated minipool solvent‐detergent treated cryoprecipitate processed in single‐use bag systems

Identifieur interne : 002A60 ( Main/Exploration ); précédent : 002A59; suivant : 002A61

Properties of a concentrated minipool solvent‐detergent treated cryoprecipitate processed in single‐use bag systems

Auteurs : T. Burnouf [France] ; C. Caron [France] ; M. Radosevich [France] ; H. A. Goubran [Égypte] ; J. Goudemand [France] ; M. El-Ekiaby [Égypte]

Source :

RBID : ISTEX:FF03D89EC6C09233E9BF62E9E0446B78DE58FC50

Descripteurs français

English descriptors

Abstract

Summary.  Cryoprecipitate is still used to treat factor VIII (FVIII), von Willebrand factor (VWF) and/or fibrinogen deficiency. Recently a solvent‐detergent (S/D) process of minipools of cryoprecipitate performed in a closed bag system has been designed to improve its viral safety. Still, cryoprecipitate has other drawbacks, including low concentration in active proteins, and presence of haemolytic isoagglutinins. We report here the biochemical evaluation of S/D‐treated minipools of cryoprecipitates depleted of cryo‐poor plasma. Cryoprecipitates were solubilized by 8 mL of a sterile glucose/saline solution, pooled in batches of 40 donations and subjected to S/D treatment in a plastic bag system using either 2% TnBP or 1% TnBP‐1%Triton X‐45, followed by oil extractions (n = 10). Mean (±SD) FVIII and fibrinogen content was 8.86 (±1.29) IU mL−1 and 16.02 (±1.98) mg mL−1, and 8.92 (±1.05) IU mL−1 in cryoprecipitate minipools treated with 2% TnBP, and 17.26 (±1.71) mg mL−1, in those treated by TnBP‐Triton X‐45, respectively. The WWF antigen, ristocetin cofactor and collagen binding activities were close to 10, 7 and 8 IU mL−1, respectively, and were not affected by either SD treatment. VWF multimeric pattern of SD‐treated cryoprecipitates were similar to that of normal plasma, and the >15 mers and >10 mers content was identical to that of the starting cryoprecipitates. The anti‐A and anti‐B titre was 0–1 and 0–1/8, respectively. Therefore, it is possible to prepare virally inactivated cryoprecipitate minipools depleted of isoagglutinins and enriched in functional FVIII, VWF and clottable fibrinogen.

Url:
DOI: 10.1111/j.1365-2516.2008.01797.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Properties of a concentrated minipool solvent‐detergent treated cryoprecipitate processed in single‐use bag systems</title>
<author>
<name sortKey="Burnouf, T" sort="Burnouf, T" uniqKey="Burnouf T" first="T." last="Burnouf">T. Burnouf</name>
</author>
<author>
<name sortKey="Caron, C" sort="Caron, C" uniqKey="Caron C" first="C." last="Caron">C. Caron</name>
</author>
<author>
<name sortKey="Radosevich, M" sort="Radosevich, M" uniqKey="Radosevich M" first="M." last="Radosevich">M. Radosevich</name>
</author>
<author>
<name sortKey="Goubran, H A" sort="Goubran, H A" uniqKey="Goubran H" first="H. A." last="Goubran">H. A. Goubran</name>
</author>
<author>
<name sortKey="Goudemand, J" sort="Goudemand, J" uniqKey="Goudemand J" first="J." last="Goudemand">J. Goudemand</name>
</author>
<author>
<name sortKey="El Kiaby, M" sort="El Kiaby, M" uniqKey="El Kiaby M" first="M." last="El-Ekiaby">M. El-Ekiaby</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FF03D89EC6C09233E9BF62E9E0446B78DE58FC50</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1111/j.1365-2516.2008.01797.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-LWSDTNTJ-Q/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000052</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000052</idno>
<idno type="wicri:Area/Istex/Curation">000052</idno>
<idno type="wicri:Area/Istex/Checkpoint">000774</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000774</idno>
<idno type="wicri:doubleKey">1351-8216:2008:Burnouf T:properties:of:a</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18565126</idno>
<idno type="wicri:Area/PubMed/Corpus">002099</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002099</idno>
<idno type="wicri:Area/PubMed/Curation">002099</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002099</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001F66</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F66</idno>
<idno type="wicri:Area/Ncbi/Merge">000610</idno>
<idno type="wicri:Area/Ncbi/Curation">000610</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000610</idno>
<idno type="wicri:Area/Main/Merge">002A86</idno>
<idno type="wicri:Area/Main/Curation">002A60</idno>
<idno type="wicri:Area/Main/Exploration">002A60</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Properties of a concentrated minipool solvent‐detergent treated cryoprecipitate processed in single‐use bag systems</title>
<author>
<name sortKey="Burnouf, T" sort="Burnouf, T" uniqKey="Burnouf T" first="T." last="Burnouf">T. Burnouf</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Human Plasma Product Services, Research Department, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Caron, C" sort="Caron, C" uniqKey="Caron C" first="C." last="Caron">C. Caron</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire d’hématologie, Hôpital Régional et Universitaire, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Radosevich, M" sort="Radosevich, M" uniqKey="Radosevich M" first="M." last="Radosevich">M. Radosevich</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Human Plasma Product Services, Research Department, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Goubran, H A" sort="Goubran, H A" uniqKey="Goubran H" first="H. A." last="Goubran">H. A. Goubran</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Faculty of Medicine, Cairo University, Cairo</wicri:regionArea>
<wicri:noRegion>Cairo</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Goudemand, J" sort="Goudemand, J" uniqKey="Goudemand J" first="J." last="Goudemand">J. Goudemand</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire d’hématologie, Hôpital Régional et Universitaire, Lille</wicri:regionArea>
<placeName>
<region type="region">Hauts-de-France</region>
<region type="old region">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="El Kiaby, M" sort="El Kiaby, M" uniqKey="El Kiaby M" first="M." last="El-Ekiaby">M. El-Ekiaby</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Shabrawishi Hospital Blood Bank, Cairo</wicri:regionArea>
<wicri:noRegion>Cairo</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Haemophilia</title>
<title level="j" type="alt">HAEMOPHILIA</title>
<idno type="ISSN">1351-8216</idno>
<idno type="eISSN">1365-2516</idno>
<imprint>
<biblScope unit="vol">14</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="956">956</biblScope>
<biblScope unit="page" to="962">962</biblScope>
<biblScope unit="page-count">7</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2008-09">2008-09</date>
</imprint>
<idno type="ISSN">1351-8216</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1351-8216</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Blood Banks</term>
<term>Blood Coagulation Factors (analysis)</term>
<term>Blood Preservation (methods)</term>
<term>Cryopreservation (methods)</term>
<term>Detergents</term>
<term>Factor VIII (analysis)</term>
<term>Fibrinogen (analysis)</term>
<term>Humans</term>
<term>Solvents</term>
<term>Virus Inactivation</term>
<term>von Willebrand Factor (analysis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Banques de sang</term>
<term>Conservation de sang ()</term>
<term>Cryoconservation ()</term>
<term>Détergents</term>
<term>Facteur VIII (analyse)</term>
<term>Facteur de von Willebrand (analyse)</term>
<term>Facteurs de la coagulation sanguine (analyse)</term>
<term>Fibrinogène (analyse)</term>
<term>Humains</term>
<term>Inactivation virale</term>
<term>Solvants</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Blood Coagulation Factors</term>
<term>Factor VIII</term>
<term>Fibrinogen</term>
<term>von Willebrand Factor</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Facteur VIII</term>
<term>Facteur de von Willebrand</term>
<term>Facteurs de la coagulation sanguine</term>
<term>Fibrinogène</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Blood Preservation</term>
<term>Cryopreservation</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Assay</term>
<term>Authors journal compilation</term>
<term>Blackwell publishing</term>
<term>Blood Banks</term>
<term>Brinogen</term>
<term>Burnouf</term>
<term>Clottable</term>
<term>Cryoprecipitate</term>
<term>Cryoprecipitate minipool</term>
<term>Cryoprecipitate minipools</term>
<term>Cryoprecipitates</term>
<term>Detergents</term>
<term>Factor viii</term>
<term>Factor willebrand factor</term>
<term>Fviii</term>
<term>Haemophilia</term>
<term>Humans</term>
<term>Mers</term>
<term>Minipool</term>
<term>Minipools</term>
<term>Multimers</term>
<term>Normal plasma</term>
<term>Respective ratios</term>
<term>Shabrawishi hospital blood bank</term>
<term>Solvents</term>
<term>Thromb</term>
<term>Thromb haemost</term>
<term>Tnbp</term>
<term>Triton</term>
<term>Viii</term>
<term>Viral</term>
<term>Viral inactivation</term>
<term>Virus Inactivation</term>
<term>Willebrand</term>
<term>Willebrand disease</term>
<term>Willebrand factor</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Banques de sang</term>
<term>Conservation de sang</term>
<term>Cryoconservation</term>
<term>Détergents</term>
<term>Humains</term>
<term>Inactivation virale</term>
<term>Solvants</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Summary.  Cryoprecipitate is still used to treat factor VIII (FVIII), von Willebrand factor (VWF) and/or fibrinogen deficiency. Recently a solvent‐detergent (S/D) process of minipools of cryoprecipitate performed in a closed bag system has been designed to improve its viral safety. Still, cryoprecipitate has other drawbacks, including low concentration in active proteins, and presence of haemolytic isoagglutinins. We report here the biochemical evaluation of S/D‐treated minipools of cryoprecipitates depleted of cryo‐poor plasma. Cryoprecipitates were solubilized by 8 mL of a sterile glucose/saline solution, pooled in batches of 40 donations and subjected to S/D treatment in a plastic bag system using either 2% TnBP or 1% TnBP‐1%Triton X‐45, followed by oil extractions (n = 10). Mean (±SD) FVIII and fibrinogen content was 8.86 (±1.29) IU mL−1 and 16.02 (±1.98) mg mL−1, and 8.92 (±1.05) IU mL−1 in cryoprecipitate minipools treated with 2% TnBP, and 17.26 (±1.71) mg mL−1, in those treated by TnBP‐Triton X‐45, respectively. The WWF antigen, ristocetin cofactor and collagen binding activities were close to 10, 7 and 8 IU mL−1, respectively, and were not affected by either SD treatment. VWF multimeric pattern of SD‐treated cryoprecipitates were similar to that of normal plasma, and the >15 mers and >10 mers content was identical to that of the starting cryoprecipitates. The anti‐A and anti‐B titre was 0–1 and 0–1/8, respectively. Therefore, it is possible to prepare virally inactivated cryoprecipitate minipools depleted of isoagglutinins and enriched in functional FVIII, VWF and clottable fibrinogen.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>Égypte</li>
</country>
<region>
<li>Hauts-de-France</li>
<li>Nord-Pas-de-Calais</li>
</region>
<settlement>
<li>Lille</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Hauts-de-France">
<name sortKey="Burnouf, T" sort="Burnouf, T" uniqKey="Burnouf T" first="T." last="Burnouf">T. Burnouf</name>
</region>
<name sortKey="Caron, C" sort="Caron, C" uniqKey="Caron C" first="C." last="Caron">C. Caron</name>
<name sortKey="Goudemand, J" sort="Goudemand, J" uniqKey="Goudemand J" first="J." last="Goudemand">J. Goudemand</name>
<name sortKey="Radosevich, M" sort="Radosevich, M" uniqKey="Radosevich M" first="M." last="Radosevich">M. Radosevich</name>
</country>
<country name="Égypte">
<noRegion>
<name sortKey="Goubran, H A" sort="Goubran, H A" uniqKey="Goubran H" first="H. A." last="Goubran">H. A. Goubran</name>
</noRegion>
<name sortKey="El Kiaby, M" sort="El Kiaby, M" uniqKey="El Kiaby M" first="M." last="El-Ekiaby">M. El-Ekiaby</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A60 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002A60 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FF03D89EC6C09233E9BF62E9E0446B78DE58FC50
   |texte=   Properties of a concentrated minipool solvent‐detergent treated cryoprecipitate processed in single‐use bag systems
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021